SEVERANCE AGREEMENTSeverance Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • California
This SEVERANCE AGREEMENT (the “Agreement”), dated July 7, 2016, is by and among Fulgent Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware corporation (“HoldCo”) and Paul Kim (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • California
This EMPLOYMENT AGREEMENT (the “Agreement”), dated May 25, 2016, is by and among Fulgent Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware corporation (“HoldCo”) and Ming Hsieh (“Executive”).
FULGENT THERAPEUTICS LLC INVESTOR’S RIGHTS AGREEMENT Dated as of May 17, 2016Investor's Rights Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • California
THIS INVESTOR’S RIGHTS AGREEMENT (this “Agreement”) is entered into effective as of May 17, 2016, by and between Fulgent Therapeutics LLC, a California limited liability company (the “Company”), and Xi Long USA, Inc., a Delaware corporation (the “Investor”). The Company and the Investor are sometimes collectively referred to herein as the “Parties” and individually as a “Party.”
CONTRIBUTION AND ALLOCATION AGREEMENTContribution and Allocation Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • California
This CONTRIBUTION AND ALLOCATION AGREEMENT (this “Agreement”) is dated as of May 19, 2016, by and among Ming Hsieh (the “Contributor”), Fulgent Pharma LLC, a California limited liability company (“Pharma”) and Fulgent Therapeutics LLC, a California limited liability company (the “Company”). Contributor, Pharma and the Company are sometimes hereinafter collectively referred to as the “Parties” and individually as a “Party.”
FORM OF AGREEMENT AND PLAN OF MERGERMerger Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of [·], 2016, by and among Fulgent Therapeutics LLC, a California limited liability company (“Therapeutics”), Fulgent Genetics, Inc., a Delaware corporation (“Genetics”), and Fulgent MergerSub, LLC, a Delaware limited liability company and a wholly owned subsidiary of Genetics (“MergerSub”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • California
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), dated May 25, 2016, is by and among Fulgent Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware corporation (“HoldCo”) and Hanlin Gao (“Executive”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • Delaware
This INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into this [●] day of [●] (the “Effective Date”) by and between Fulgent Diagnostics, Inc., a Delaware corporation (the “Company”), and [●] (the “Indemnitee”).
l ] Shares Fulgent Genetics, Inc. Common Stock, par value $0.0001 per share UNDERWRITING AGREEMENTUnderwriting Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • New York
